Follow $CTKB

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $CTKB by email
NASDAQ NMS - GLOBAL MARKET · CTKB
-0.66% · -$0.0300 · Vol 70.6K
Live · updated 10:25:16 ET
Cytek Biosciences Inc

Cytek Biosciences Inc

Life Sciences Tools & Services
$4.55
Card
Relationship Map

Veridion Score

BETALOW CONF · 6/6 factorsMethodology
CTKB
Cytek Biosciences Inc
Tue Aug 25 · last completed session · daily score · 16h old
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Confidence: LOW · 6/6 factors with data · Tue Aug 25 · last completed session · daily score · 16h old
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is CTKB moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading CTKB catalysts
About Cytek Biosciences Inc
LABORATORY ANALYTICAL INSTRUMENTS
Listed since
2021
Employees
702
Country
US

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.

Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.53
Day high
$4.58
Day low
$4.51
Previous close
$4.58
52W high
$5.88
-22.62% from high
52W low
$3.35
47% of range
Market cap
$595.3M
Beta
0.39
Shares out
130M
Volume
70.6K
0.09× rel vol
Avg volume
795.7K
VWAP
$4.54
Price history computed in-house
1W
-3.19%
1M
+3.17%
3M
+10.44%
1Y
+9.37%
YTD
-9.90%
SMA 50 $4.45 · above
SMA 200 $4.62 · below
52W position 47%

CTKB overview

Loading financial statements
Loading CTKB Form 4 filings
Public disclosures

Congress activity in CTKB

No receipt-qualified Congressional disclosure is present for CTKB in the cached public ledger.

Federal contracts

CTKB contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for CTKB in this window.
Lobbying spend

CTKB lobbying filings, year to date.

Registered lobbying filings matched to Cytek Biosciences Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for CTKB in this window.
Loading news for CTKB
Analyst ratings
Sovereign unlock shows live analyst consensus for CTKB.
Options
Sovereign unlock shows live options positioning for CTKB.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.